Changes of Brain Structure in Patients With Metastatic Non-Small Cell Lung Cancer After Long-Term Target Therapy With EGFR-TKI

Changes of Brain Structure in Patients With Metastatic Non-Small Cell Lung Cancer After Long-Term Target Therapy With EGFR-TKI

PurposeEpidermal growth factor receptor-tyrosine kinase inhibitor (EGFR-TKI) therapy is the routine treatment for patients with metastatic non-small cell lung cancer (NSCLC) harboring positive EGFR mutations. Patients who undergo such treatment have reported cognitive decline during follow-up. This...

Full description

Bibliographic Details
Main Authors: Beisheng Yang, Chunli Luo, Min Yu, Lin Zhou, Bo Tao, Biqiu Tang, Ying Zhou, Jiang Zhu, Meijuan Huang, Feng Peng, Yongmei Liu, Yong Xu, Yan Zhang, Xiaojuan Zhou, Jianxin Xue, Yanying Li, Yongsheng Wang, Zhiping Li, You Lu, Su Lui, Youling Gong
Format: Article
Language:English
Published: Frontiers Media S.A. 2021-01-01
Series:Frontiers in Oncology
Subjects:
non-small cell lung cancer
epidermal growth factor receptor-tyrosine kinase inhibitor
white matter lesion
gray matter
MRI
Online Access:https://www.frontiersin.org/articles/10.3389/fonc.2020.573512/full

Internet

https://www.frontiersin.org/articles/10.3389/fonc.2020.573512/full

Similar Items